Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma
Clinical trial NCT05798793 · RECRUITING
Trial details
- NCT number
- NCT05798793
- Sponsor
- Hospital of Stomatology, Wuhan University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-21
- Primary completion
- 2026-07-01
- Enrollment
- 309
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.